TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Top Indian ministers in hospital as virus cases breach 50,000 for fifth day

News Desk (Reuters)
Bengaluru, India
Mon, August 3, 2020

Share This Article

Change Size

Top Indian ministers in hospital as virus cases breach 50,000 for fifth day A sponge with toothpicks is seen inside a lift to prevent people from touching the lift buttons with their bare hands at a residential society, amid the outbreak of the COVID-19, in Mumbai, India, on Sunday. (REUTERS/Francis Mascarenhas)

I

ndia's interior minister and the chiefs of two big states have been hospitalized with COVID-19 as the country's daily cases topped 50,000 for a fifth straight day on Monday.

The country reported 52,972 new confirmed infections in the past 24 hours, taking the total to 1.8 million - the third highest in the world after the United States and Brazil - data from India's Ministry of Health and Family Welfare showed on Monday.

With 771 new deaths, the COVID-19 disease has now killed 38,135 people in India, including that of a minister on Sunday in the most-populous state of Uttar Pradesh.

On Sunday, federal interior minister Amit Shah, one of Prime Minister Narendra Modi's closest aides, as well as the chief minister of the southern state of Karnataka, were hospitalized. The chief of the central state of Madhya Pradesh is also recovering in hospital.

It was not immediately clear whether Shah's cabinet colleagues, including the finance minister, had isolated themselves.

As infections continue to surge in the country, having registered a record of 57,118 on Saturday, India has also stepped up efforts to test more people and search for a vaccine.

The health ministry said on Twitter that the country's drugs authorities had allowed Serum Institute of India, the world's largest manufacturer of vaccines by volume, to conduct clinical trials of a vaccine candidate developed by Oxford University and AstraZeneca Plc. 

 

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.